Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers

• Published in: Disease markers Vol. 2020; no. 2020; pp. 1 - 21
• Main Authors: Berezin, Alexander E., Berezin, Alexander A.
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 2020; Hindawi; John Wiley & Sons, Inc
• Subjects: Adrenomedullin; Atherosclerosis; Biological markers; Biomarkers; Biomechanics; Blood flow; C-reactive protein; Cardiac arrhythmia; Cardiac patients; Cardiovascular diseases; Clinical outcomes; Complications; Coronary artery; Diabetes; Diagnostic systems; Ejection fraction; Fibrosis; Health risks; Heart attack; Heart attacks; Heart failure; Hypertension; Ischemia; Medical prognosis; Mortality; Myocardial infarction; Necrosis; New technology; Pathogenesis; Peptides; Prevention; Prognosis; Review; Risk analysis; Risk factors; Stenosis; Stents; Thrombosis; Tomography; Transluminal angioplasty; Utilities; Veins & arteries

The prevalence of heart failure (HF) due to cardiac remodelling after acute myocardial infarction (AMI) does not decrease regardless of implementation of new technologies supporting opening culprit coronary artery and solving of ischemia-relating stenosis with primary percutaneous coronary intervent...